Cargando…

Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe

The conventional targeted delivery of chemotherapeutic and diagnostic agents utilizing nanocarriers is a promising approach for cancer theranostics. Unfortunately, this approach often faces hindered tumor access that decreases the therapeutic index and limits the further clinical translation of a de...

Descripción completa

Detalles Bibliográficos
Autores principales: Yabbarov, Nikita, Nikolskaya, Elena, Sokol, Maria, Mollaeva, Mariia, Chirkina, Margarita, Seregina, Irina, Gulyaev, Mikhail, Pirogov, Yury, Petrov, Rem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955029/
https://www.ncbi.nlm.nih.gov/pubmed/35328540
http://dx.doi.org/10.3390/ijms23063119
_version_ 1784676238767423488
author Yabbarov, Nikita
Nikolskaya, Elena
Sokol, Maria
Mollaeva, Mariia
Chirkina, Margarita
Seregina, Irina
Gulyaev, Mikhail
Pirogov, Yury
Petrov, Rem
author_facet Yabbarov, Nikita
Nikolskaya, Elena
Sokol, Maria
Mollaeva, Mariia
Chirkina, Margarita
Seregina, Irina
Gulyaev, Mikhail
Pirogov, Yury
Petrov, Rem
author_sort Yabbarov, Nikita
collection PubMed
description The conventional targeted delivery of chemotherapeutic and diagnostic agents utilizing nanocarriers is a promising approach for cancer theranostics. Unfortunately, this approach often faces hindered tumor access that decreases the therapeutic index and limits the further clinical translation of a developing drug. Here, we demonstrated a strategy of simultaneously double-targeting the drug to two distinct cites of tumor tissue: the tumor endothelium and cell surface receptors. We used fourth-generation polyamideamine dendrimers modified with a chelated Gd and functionalized with selectin ligand and alpha-fetoprotein receptor-binding peptide. According to the proposed strategy, IELLQAR peptide promotes the conjugate recruitment to the tumor inflammatory microenvironment and enhances extravasation through the interaction of nanodevice with P- and E-selectins expressed by endothelial cells. The second target moiety—alpha-fetoprotein receptor-binding peptide—enhances drug internalization into cancer cells and the intratumoral retention of the conjugate. The final conjugate contained 18 chelated Gd ions per dendrimer, characterized with a 32 nm size and a negative surface charge of around 18 mV. In vitro contrasting properties were comparable with commercially available Gd-chelate: r1 relaxivity was 3.39 for Magnevist and 3.11 for conjugate; r2 relaxivity was 5.12 for Magnevist and 4.81 for conjugate. By utilizing this dual targeting strategy, we demonstrated the increment of intratumoral accumulation, and a remarkable enhancement of antitumor effect, resulting in high-level synergy compared to monotargeted conjugates. In summary, the proposed strategy utilizing tumor tissue double-targeting may contribute to an enhancement in drug and diagnostic accumulation in aggressive tumors.
format Online
Article
Text
id pubmed-8955029
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89550292022-03-26 Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe Yabbarov, Nikita Nikolskaya, Elena Sokol, Maria Mollaeva, Mariia Chirkina, Margarita Seregina, Irina Gulyaev, Mikhail Pirogov, Yury Petrov, Rem Int J Mol Sci Article The conventional targeted delivery of chemotherapeutic and diagnostic agents utilizing nanocarriers is a promising approach for cancer theranostics. Unfortunately, this approach often faces hindered tumor access that decreases the therapeutic index and limits the further clinical translation of a developing drug. Here, we demonstrated a strategy of simultaneously double-targeting the drug to two distinct cites of tumor tissue: the tumor endothelium and cell surface receptors. We used fourth-generation polyamideamine dendrimers modified with a chelated Gd and functionalized with selectin ligand and alpha-fetoprotein receptor-binding peptide. According to the proposed strategy, IELLQAR peptide promotes the conjugate recruitment to the tumor inflammatory microenvironment and enhances extravasation through the interaction of nanodevice with P- and E-selectins expressed by endothelial cells. The second target moiety—alpha-fetoprotein receptor-binding peptide—enhances drug internalization into cancer cells and the intratumoral retention of the conjugate. The final conjugate contained 18 chelated Gd ions per dendrimer, characterized with a 32 nm size and a negative surface charge of around 18 mV. In vitro contrasting properties were comparable with commercially available Gd-chelate: r1 relaxivity was 3.39 for Magnevist and 3.11 for conjugate; r2 relaxivity was 5.12 for Magnevist and 4.81 for conjugate. By utilizing this dual targeting strategy, we demonstrated the increment of intratumoral accumulation, and a remarkable enhancement of antitumor effect, resulting in high-level synergy compared to monotargeted conjugates. In summary, the proposed strategy utilizing tumor tissue double-targeting may contribute to an enhancement in drug and diagnostic accumulation in aggressive tumors. MDPI 2022-03-14 /pmc/articles/PMC8955029/ /pubmed/35328540 http://dx.doi.org/10.3390/ijms23063119 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yabbarov, Nikita
Nikolskaya, Elena
Sokol, Maria
Mollaeva, Mariia
Chirkina, Margarita
Seregina, Irina
Gulyaev, Mikhail
Pirogov, Yury
Petrov, Rem
Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe
title Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe
title_full Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe
title_fullStr Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe
title_full_unstemmed Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe
title_short Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe
title_sort synergetic enhancement of tumor double-targeted mri nano-probe
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955029/
https://www.ncbi.nlm.nih.gov/pubmed/35328540
http://dx.doi.org/10.3390/ijms23063119
work_keys_str_mv AT yabbarovnikita synergeticenhancementoftumordoubletargetedmrinanoprobe
AT nikolskayaelena synergeticenhancementoftumordoubletargetedmrinanoprobe
AT sokolmaria synergeticenhancementoftumordoubletargetedmrinanoprobe
AT mollaevamariia synergeticenhancementoftumordoubletargetedmrinanoprobe
AT chirkinamargarita synergeticenhancementoftumordoubletargetedmrinanoprobe
AT sereginairina synergeticenhancementoftumordoubletargetedmrinanoprobe
AT gulyaevmikhail synergeticenhancementoftumordoubletargetedmrinanoprobe
AT pirogovyury synergeticenhancementoftumordoubletargetedmrinanoprobe
AT petrovrem synergeticenhancementoftumordoubletargetedmrinanoprobe